NLS
January 15, 2017
[aas_zone zone_id=”7910″]
Published: January 15, 2017
Top stories
In a new job – April 13, 2026
After 36 years, my chapter at Novo Nordisk is coming to a close, writes the inventor of the GLP-1 receptor agonist liraglutide on LinkedIn.
Pernilla Sandwall and Marie Gårdmark bring extensive senior leadership experience from the life sciences sector with special focus on clinical research and regulatory strategy in pharma/medtech development.
Clinical Trials – April 13, 2026
The company has completed preparations and received all regulatory approvals for the VITAL-CML trial.
Biotech Business – April 13, 2026
In parallel with ongoing partnering activities, Alligator is exploring alternative opportunities for phase 3 development of mitazalimab in first line metastatic pancreatic cancer.
Related posts
Advertising free banner - January 15, 2017
[aas_zone zone_id=”8010″]
[aas_zone zone_id=”7909″]
[aas_zone zone_id=”7913″]
[aas_zone zone_id=”7915″]
This site uses cookies
Read more about our privacy policy
The "Functional" cookie category includes cookies that are essential for the smooth operation of our website and to enhance your browsing experience. These cookies enable various functionalities that make our site more user-friendly and efficient.
The "Market" cookie category encompasses cookies used to analyze and improve our marketing efforts. These cookies help us understand how you interact with our website and provide us with insights to optimize our content and advertisements, ensuring they are relevant to your interests.
The "Personal" cookie category includes cookies that enhance the user experience by storing information about your preferences and interactions on our site. This allows us to tailor content and recommendations to your individual needs, providing a more personalized and engaging experience.